Inclusive of all taxes
MONTRELIEF BL TAB by Dr Precision is an advanced dual-action oral tablet specially formulated to manage and prevent respiratory conditions such as asthma, allergic rhinitis, and chronic obstructive pulmonary disease (COPD). This combination medication incorporates Montelukast, a leukotriene receptor antagonist that reduces airway inflammation and allergic reactions, with Bambuterol, a long-acting β2-adrenergic agonist that relaxes bronchial smooth muscles to prevent bronchospasms and facilitate better airflow. Manufactured under stringent WHO-GMP compliant standards, MONTRELIEF BL TAB ensures high quality, safety, and efficacy in controlling symptoms like wheezing, nasal congestion, sneezing, and shortness of breath. Its optimized pharmacokinetic profile allows for prolonged action, reducing dosing frequency and enhancing patient adherence. Suitable for both pediatric and adult patients under medical supervision, this formulation is ideal for long-term respiratory care, offering both preventive and symptomatic relief. Packaged securely for transportation and storage, MONTRELIEF BL TAB represents a reliable and cost-effective solution for healthcare providers, pharmaceutical distributors, and hospitals aiming to expand their respiratory therapy offerings in domestic and international markets.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Montelukast and Bambuterol |
| Therapeutic Action | Dual-action anti-allergic and bronchodilator effects |
| Indications | Management of asthma, allergic rhinitis, and COPD |
| Formulation | Oral tablet for optimal absorption and prolonged effect |
| Manufacturing Standards | WHO-GMP compliant production |
| Packaging | Robust packaging ensuring stability and integrity during transport |
| Dosage Frequency | Prolonged action reduces need for frequent dosing |
| Patient Suitability | Pediatric and adult use under medical supervision |
| Quality Assurance | Rigorous quality checks and stability testing |
| Market Application | Suitable for domestic and global pharmaceutical distribution |
| Attributes | Description |
|---|---|
| Montelukast Content | 10 mg per tablet |
| Bambuterol Content | 10 mg per tablet |
| Dosage Form | Oral tablet |
| Pharmacological Class | Leukotriene receptor antagonist and long-acting β2-agonist |
| Shelf Life | 24 months from manufacturing date |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Manufacturer | Bluepill Express under Dr Precision label |
| Compliance | Manufactured in WHO-GMP certified facilities |
| Prescription Status | Prescription-only medication |
| Packaging Type | Blister packs/strip packs with protective overwrap |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
MONTRELIEF BL TAB combines Montelukast, which prevents airway inflammation by blocking leukotriene receptors, with Bambuterol, which relaxes airway muscles to immediately relieve bronchospasms. This dual mechanism addresses both underlying inflammation and acute symptoms for comprehensive respiratory management.
Yes, MONTRELIEF BL TAB is formulated for both pediatric and adult use but should be taken strictly under medical supervision to ensure appropriate dosing and safety.
This product is manufactured in WHO-GMP certified facilities under the Dr Precision label, ensuring adherence to international quality, safety, and efficacy standards.
Bambuterol acts as a long-acting β2-adrenergic agonist that relaxes bronchial smooth muscles, reducing bronchospasm frequency and improving airflow, thereby complementing Montelukast’s anti-inflammatory action.
The oral tablet offers optimized pharmacokinetics for effective absorption and prolonged therapeutic action, which reduces dosing frequency and enhances patient compliance in long-term respiratory treatment.
Yes, Montelukast in the formulation helps alleviate allergic rhinitis symptoms such as nasal congestion, sneezing, and itchy eyes by blocking leukotrienes involved in allergic inflammation.
Country Of Origin: India
MONTRELIEF BL TAB is a dual-action anti-allergic and bronchodilator formulation that combines Montelukast and Bambuterol. It is used in the management of asthma, allergic rhinitis, and other respiratory conditions by reducing airway inflammation, preventing bronchospasm, and relieving allergy symptoms.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
MONTRELIEF BL TAB is a scientifically advanced combination medication that brings together the therapeutic strengths of Montelukast and Bambuterol to manage and prevent respiratory disorders such as bronchial asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. Montelukast functions as a leukotriene receptor antagonist, blocking substances in the body that cause narrowing and swelling of airways. This helps in reducing inflammation, mucus production, and symptoms like wheezing and shortness of breath. Bambuterol, a long-acting β2-adrenergic agonist, works by relaxing the smooth muscles of the airways, facilitating easier breathing and preventing bronchospasms.
The combination of Montelukast and Bambuterol in MONTRELIEF BL TAB offers both preventive and symptomatic relief, making it suitable for patients who require long-term asthma control and relief from allergic symptoms such as nasal congestion, sneezing, and itchy eyes. This dual benefit significantly improves respiratory function and overall quality of life in patients suffering from chronic respiratory illnesses.
Manufactured by Bluepill Express in WHO-GMP compliant facilities, MONTRELIEF BL TAB adheres to international standards of quality, safety, and efficacy. Each tablet undergoes rigorous quality checks and stability testing to ensure consistent performance and therapeutic reliability. The formulation is presented in a convenient oral tablet form with optimal pharmacokinetics for effective absorption and prolonged action, minimizing the need for frequent dosing.
Its utility extends to pediatric and adult populations under medical supervision, and the tablet is especially beneficial in scenarios where patients require both anti-inflammatory and bronchodilatory effects. MONTRELIEF BL TAB is available in robust packaging that maintains the integrity of the medication during transportation and storage, making it an ideal product for both domestic consumption and global export.
Given the increasing global burden of asthma and allergic respiratory conditions, MONTRELIEF BL TAB stands out as a reliable, cost-effective, and clinically validated option for healthcare providers and pharmaceutical distributors looking to expand their respiratory care portfolio.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
